Imagine walking into your doctor's office feeling sick—and rather than flipping through pages of your medical history or running tests that take days, your doctor instantly pulls together data from ...

“The potential is to give oncology experts the ultimate tool for navigating cancer’s complexity,” explains Berke. “AI that ...

Key Takeaways Tempus AI stock shows 15–32% upside potential based on analyst forecasts.The company leads in using artificial ...

A novel artificial intelligence (AI) application capable of diagnosing endocrine cancers with speed and accuracy is being ...

The WHO technical brief recognizes India’s sweeping efforts to integrate AI with its diverse Ayush systems, including Ayurveda, Siddha, Unani, Sowa Rigpa, and Homoeopathy.

Launched with a gift from the Biswas Family Foundation, it aims to apply cutting-edge research to improve health care ...

Hayward's Aqtual raises $31M to commercialize a blood test for rheumatoid arthritis, aiming to launch in 2026 after clinical ...

Cobionix Corp., a Canada-based medical robotics company, today announced it closed a $3 million funding round led by TitletownTech, a venture capital firm backed by Microsoft Corp. and the Green Bay ...

Berkeley scientists have developed a smartphone-based biosensor that mimics coffee-ring physics to detect disease proteins ...

Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and ...